Sari Reisner on the benefits of gender-affirming hormone therapy on HIV clinical outcomes
The Lancet HIV in conversation with - En podkast av The Lancet Group
Kategorier:
Sari Reisner (University of Michigan School of Public Health, Boston, USA) on gender-affirming hormone therapy for transgender, non-binary, and gender-diverse people in the US and its effects on HIV acquisition risk and viral suppression. Read the article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00004-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv And the personal view: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00299-6/fulltext?dgcid...
